Sequence-specific modification of mouse genomic DNA mediated by gene targeting techniques

Cytogenetic and Genome Research

Volumn 105, Issue 2-4, 2004, Pages 435-441

  Sangiuolo, F ^a   Novelli, G ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; DNA FRAGMENT; DYSTROPHIN; GENOMIC DNA; GLUCURONOSYLTRANSFERASE; LIPOSOME; OLIGONUCLEOTIDE; POLYETHYLENEIMINE DERIVATIVE;

CHIMERAPLASTY; CRIGLER NAJJAR SYNDROME; DNA DAMAGE; DNA HELIX; DNA MODIFICATION; DNA REPAIR; DNA STRUCTURE; DUCHENNE MUSCULAR DYSTROPHY; EXCISION REPAIR; FIBROBLAST; GENE DELETION; GENE SEQUENCE; GENE TARGETING; GENETIC DISORDER; HEMATOPOIETIC STEM CELL; HOMOLOGOUS RECOMBINATION; HUMAN; IMMUNOBLOTTING; LUNG ALVEOLUS EPITHELIUM; LUNG SARCOMA; MISMATCH REPAIR; MUTAGENESIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SOMATIC CELL; STOP CODON;

ANIMALS; DNA; DNA REPAIR; GENE TARGETING; GENE THERAPY; GENOME; HUMANS; MICE; OLIGONUCLEOTIDES; RECOMBINATION, GENETIC; RNA;

EUKARYOTA; PROKARYOTA;

EID: 3242798871     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078216     Document Type: Review

References (51)

1. Albuquerque-Silva J, Vassert G, Lavinha J: Chimeraplasty validation. Nat Biotechnol 19:1011 (2001).
2. Alexeev V and Yoon K: Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide. Nat Biotechnol 16:1343-1346 (1998).
3. Bartlett RJ, Stockinger S, Denis MM, Bartlett WT, Inverardi L, Le TT, thi Man N, Morris GE, Bogan DJ, Metcalf-Bogan J, Kornegay JN: In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide. Nat Biotechnol 18:615-622 (2000).
4. Bar-Ziv R, Libchaber A: Effects of DNA sequence and structure on binding of RecA to single-stranded DNA. Proc Natl Acad Sci USA 98:9068-9073 (2001).
5. Bertoni C, Lau C, Rando TA: Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping. Hum Mol Genet 12:1087-1099 (2003).
6. Brown J, Brown T, Fox KR: Affinity of mismatch-binding protein MutS for heteroduplexes containing different mismatches. Biochem J 354(Pt 3):627-633 (2001).
7. Bruscia E, Sangiuolo F, Sinibaldi, Goncz KK, Novelli G, Gruenert DC: Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting. Gene Ther 9:683-685 (2002).
8. Casey BP, Glazer PM: Gene targeting via triple-helix formation. Prog Nucleic Acid Res Mol Biol 67:163-192 (2001).
9. Davis BR, Brown DB, Prokopishyn NL, Yannariello-Brown J: Micro-injection-mediated hematopoietic stem cell gene therapy. Curr Opin Mol Ther 2:412-419 (2000).
10. Faruqi AF, Datta HJ, Carroll D, Seidman MM, Glazer PM: Triple-helix formation induces recombination in mammalian cells via a nucleotide excision repair-dependent pathway. Mol Cell Biol 20:990-1000 (2000).
11. Goncz KK, Gruenert DC: Site-directed alteration of genomic DNA by small-fragment homologous replacement. Methods Mol Biol 133:85-99 (2000).
12. Goncz KK, Kunzelmann K, Xu Z, Gruenert DC: Targeted replacement of normal and mutant CFTR sequences in human airway epithelial cells using DNA fragments. Hum Mol Genet 7:1913-1919 (1998).
13. Goncz KK, Colosimo A, Dallapiccola B, Gagne L, Hong K, Novelli G, Papahadjopoulos D, Sawa T, Schreier H, Wiener-Kronish J, Xu S, Gruenert DC: Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR. Gene Ther 8:961-965 (2001).
14. Goncz KK, Prokopishyn NL, Chow BL, Davis BR, Gruenert DC: Application of SFHR to gene therapy of monogenic disorders. Gene Ther 9:691-694 (2002).
15. Gruenert DC: Gene correction with small DNA fragments. Curr Res Molec Ther 1:607-613 (1998).
16. Gruenert DC: Opportunities and challenges in targeting genes for therapy. Gene Ther 6:1347-1348 (1999).
17. Gruenert DC, Xu Z, Wiener-Kronish J, Colledge WH, Radcliff R, Mc Vinish L, Goncz KK: Gene targeting in somatic cells: prospects for the future of gene therapy. 6th Max Delbruck Symposium on Gene Therapy, May 6-8, 1998 (Berlin, Germany, 1998).
18. Gruenert DC, Bruscia E, Novelli G, Colosimo A, Dallapiccola B, Sangiuolo F, Goncz KK: Sequence-specific modification of genomic DNA by small DNA fragments. J Clin Invest 112:637-641 (2003).
19. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A: A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348:193-194 (2003a).
20. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, De Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M: LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCIDX1. Science 302:415-419 (2003b).
21. Hatada S, Nikkuni K, Bentley SA, Kirby S, Smithies O: Gene correction in hematopoietic progenitor cells by homologous recombination. Proc Natl Acad Sci USA 97:13807-13811 (2000).
22. Kapsa R, Quigley A, Lynch GS, et al: In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement. Hum Gene Ther 12:629-642 (2001).
23. Kapsa RM, Quigley AF, Vadolas J, Steeper K, Ioannou PA, Byrne E, Kornberg AJ: Targeted gene correction in the mdx mouse using short DNA fragments: towards application with bone marrow-derived cells for autologous remodelling of dystrophic muscle. Gene Ther 9:695-699 (2002).
24. Kmiec EB: Targeted gene repair. Gene Ther 6:1-3 (1999).
25. Kmiec EB: Targeted gene repair - in the arena. J Clin Invest 112:632-636 (2003).
26. Kren BT, Bandyopadhyay P, Steer CJ: In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med 4:285-290 (1998).
27. Kren BT, Parashar B, Bandyopadhyay P, Chowdhury NR, Chowdhury JR, Steer CJ: Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of Crigler-Najjar syndrome type I with a chimeric oligonucleotide. Proc Natl Acad Sci USA 96:10349-10354 (1999).
28. Igoucheva O, Yoon K: Targeted single-base correction by RNA-DNA oligonucleotides. Hum Gene Ther 11:2307-2312 (2000).
29. Luo Z, Macris MA, Faruqi AF, Glazer PM: High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells. Proc Natl Acad Sci USA 97:9003-9008 (2000).
30. Majumdar A, Khorlin A, Dyatkina N, Lin FL, Powell J, Liu J, Fei Z, Khripine Y, Watanabe KA, George J, Glazer PM, Seidman MM: Targeted gene knockout mediated by triple helix forming oligonucleotides. Nat Genet 20:212-214 (1998).
31. Modrich P: Strand-specific mismatch repair in mammalian cells. J Biol Chem 272:24727-24730 (1997).
32. Muller K, Heller H, Doerfler W: Foreign DNA integration. Genome-wide perturbations of methylation and transcription in the recipient genomes. J Biol Chem 276:14271-14278 (2001).
33. Nickerson HD, Colledge WH: A comparison of gene repair strategies in cell culture using a lacZ reporter system. Gene Ther 10: 1584-1591 (2003).
34. Raha M, Lacroix L, Glazer PM: Mutagenesis mediated by triple helix-forming oligonucleotides conjugated to psoralen: effects of linker arm length and sequence context. Photochem Photobiol 67:289-294 (1998).
35. Rando TA, Disatnik M-H, Zhou LZ-H: Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides. Proc Natl Acad Sci USA 97:5363-5368 (2000).
36. Remus R, Kammer C, Heller H, Schmitz B, Schell G, Doerfler W: Insertion of foreign DNA into an established mammalian genome can alter the methylation of cellular DNA sequences. J Virol 73:1010-1022 (1999).
37. Schindelhauer D, Laner A: Visible transient expression of EGFP requires intranuclear injection of large copy numbers. Gene Ther 9:727-730 (2002).
38. Sullenger BA: Targeted genetic repair: an emerging approach to genetic therapy. J Clin Invest 112:310-311 (2003).
39. Thomas KR, Capecchi MR: Recombinant DNA technique and sickle cell anemia research. Science 275:1404-1405 (1997).
40. Torigoe H, Kawahashi K, Tamura Y: Promotion of triplex formation by morpholino modification: thermodynamic and kinetic studies. Nucleic Acids Res 3:157-158 (2003).
41. van der Steege G, Schuilenga-Hut PHL, Buys CHMC, Scheffer H, Pas HH, Jonkman MF: Persistent failures in gene repair. Nat Biotechnol 19:305-306 (2001).
42. Vasquez KM, Wang G, Havre PA, Glazer PM: Chromosomal mutations induced by triplex-forming oligonucleotides in mammalian cells. Nucleic Acids Res 27:1176-1181 (1999)
43. Vasquez KM, Narayanan L, Glazer PM: Specific mutations induced by triplex-forming oligonucleotides in mice. Science 290:530-533 (2000).
44. Vasquez KM, Marburger K, Intody Z, Wilson JH: Manipulating the mammalian genome by homologous recombination. Proc Natl Acad Sci USA 98:8403-8410 (2001a).
45. Vasquez KM, Dagle JM, Weeks DL, Glazer PM: Chromosome targeting at short polypurine sites by cationic triplex-forming oligonucleotides. J Biol Chem 276:38536-38541 (2001b).
46. Williams DA, Baum C: Gene therapy-new challenges ahead. Science 302:400-401 (2003).
47. Wu XS, Liu DP, Liang CC: Prospects of chimeric RNA-DNA oligonucleotides in gene therapy. J Biomed Sci 8:439-445 (2001).
48. Yanez J, Porter AC: Therapeutic gene targeting. Gene Ther 5:149-159 (1998).
49. Zhang Z, Eriksson M, Falk G, Graff C, Presnell SC, Read MS, Nichols TC, Blomback M, Anvret M: Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observed. Antisense Nucleic Acid Drug Dev 8:531-536 (1998).
50. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA: In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19:1129-1133 (2001).
51. Zwaka TP, Thomson J: Homologous recombination in human embryonic stem cells. Nat Biotechnol 21:319-321 (2003).